Successful Treatment of Small-Cell Lung Cancer With Irinotecan in a Hemodialysis Patient With End-Stage Renal Disease
The Korean Journal of Internal Medicine
; : 73-75, 2009.
Article
en En
| WPRIM
| ID: wpr-12975
Biblioteca responsable:
WPRO
ABSTRACT
The prognosis of patients with end-stage renal disease has improved with advances in hemodialysis techniques. However, many patients who undergo hemodialysis suffer from various types of cancer. Limited data is available to guide clinical management of these patients who may have impaired renal function. Here, we report our experience with the use of irinotecan for the treatment of a hemodialysis patient with small-cell lung cancer and end-stage renal disease.
Palabras clave
Texto completo:
1
Base de datos:
WPRIM
Asunto principal:
Camptotecina
/
Estudios de Seguimiento
/
Diálisis Renal
/
ADN-Topoisomerasas de Tipo I
/
Supervivencia sin Enfermedad
/
Carcinoma Pulmonar de Células Pequeñas
/
Fallo Renal Crónico
/
Neoplasias Pulmonares
/
Antineoplásicos Fitogénicos
Tipo de estudio:
Observational_studies
/
Prognostic_studies
Límite:
Humans
/
Male
Idioma:
En
Revista:
The Korean Journal of Internal Medicine
Año:
2009
Tipo del documento:
Article